164 related articles for article (PubMed ID: 15295705)
21. [Epstein-Barr virus (EBV)].
Seigneurin JM
Rev Prat; 1999 Dec; 49(20):2217-21. PubMed ID: 10731805
[TBL] [Abstract][Full Text] [Related]
22. Biology of Epstein-Barr virus during infectious mononucleosis.
Sitki-Green DL; Edwards RH; Covington MM; Raab-Traub N
J Infect Dis; 2004 Feb; 189(3):483-92. PubMed ID: 14745706
[TBL] [Abstract][Full Text] [Related]
23. A molecular link between malaria and Epstein-Barr virus reactivation.
Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
[TBL] [Abstract][Full Text] [Related]
24. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
25. Expression of the recombination activating genes (RAG1 and RAG2) is not detectable in Epstein-Barr virus-associated human lymphomas.
Meru N; Jung A; Lisner R; Niedobitek G
Int J Cancer; 2001 Apr; 92(1):75-8. PubMed ID: 11279609
[TBL] [Abstract][Full Text] [Related]
26. Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis.
Faber C; Morbach H; Singh SK; Girschick HJ
Ann Rheum Dis; 2006 Oct; 65(10):1351-6. PubMed ID: 16504994
[TBL] [Abstract][Full Text] [Related]
27. Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis.
Rocchi G; Felici A; Ragona G; Heinz A
N Engl J Med; 1977 Jan; 296(3):132-4. PubMed ID: 187934
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus load in cerebrospinal fluid of patients with chronic active Epstein-Barr virus infection.
Ohga S; Sanefuji M; Ishimura M; Nomura A; Torisu H; Kira R; Takada H; Mizuno Y; Kazuyama Y; Hara T
Pediatr Infect Dis J; 2008 Nov; 27(11):1027-30. PubMed ID: 18833029
[TBL] [Abstract][Full Text] [Related]
29. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
Shibata Y; Hoshino Y; Hara S; Yagasaki H; Kojima S; Nishiyama Y; Morishima T; Kimura H
J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
[TBL] [Abstract][Full Text] [Related]
30. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
Piriou ER; van Dort K; Weel JF; Bemelman FJ; Gamadia LE; van Oers MH; van Baarle D
Clin Immunol; 2006 Apr; 119(1):16-20. PubMed ID: 16386961
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus BZLF1 gene promoter variants in pediatric patients with acute infectious mononucleosis: its comparison with pediatric lymphomas.
Lorenzetti MA; Gutiérrez MI; Altcheh J; Moscatelli G; Moroni S; Chabay PA; Preciado MV
J Med Virol; 2009 Nov; 81(11):1912-7. PubMed ID: 19774688
[TBL] [Abstract][Full Text] [Related]
32. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
[TBL] [Abstract][Full Text] [Related]
33. Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection.
Ito Y; Shibata-Watanabe Y; Ushijima Y; Kawada J; Nishiyama Y; Kojima S; Kimura H
J Infect Dis; 2008 Mar; 197(5):663-6. PubMed ID: 18260761
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
35. Transmembrane BAFF from rheumatoid synoviocytes requires interleukin-6 to induce the expression of recombination-activating gene in B lymphocytes.
Rochas C; Hillion S; Saraux A; Mageed RA; Youinou P; Jamin C; Devauchelle V
Arthritis Rheum; 2009 May; 60(5):1261-71. PubMed ID: 19404965
[TBL] [Abstract][Full Text] [Related]
36. Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma.
Khan G; Lake A; Shield L; Freeland J; Andrew L; Alexander FE; Jackson R; Taylor PR; McCruden EA; Jarrett RF
Br J Haematol; 2005 May; 129(4):511-9. PubMed ID: 15877733
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-encoded dUTPase modulates immune function and induces sickness behavior in mice.
Padgett DA; Hotchkiss AK; Pyter LM; Nelson RJ; Yang E; Yeh PE; Litsky M; Williams M; Glaser R
J Med Virol; 2004 Nov; 74(3):442-8. PubMed ID: 15368518
[TBL] [Abstract][Full Text] [Related]
38. B lymphocytopenia in infectious mononucleosis.
Sumaya CV; Keightley RG
Clin Exp Immunol; 1981 Feb; 43(2):298-301. PubMed ID: 6268336
[TBL] [Abstract][Full Text] [Related]
39. Acute infectious mononucleosis and coincidental measles virus infection.
Atrasheuskaya AV; Kameneva SN; Neverov AA; Ignatyev GM
J Clin Virol; 2004 Oct; 31(2):160-4. PubMed ID: 15364274
[TBL] [Abstract][Full Text] [Related]
40. Recombination activating genes (RAG) induce secondary Ig gene rearrangement in and subsequent apoptosis of human peripheral blood circulating B lymphocytes.
Nagafuchi H; Yoshikawa H; Takeba Y; Nara K; Miura K; Kurokawa MS; Suzuki N
Clin Exp Immunol; 2004 Apr; 136(1):76-84. PubMed ID: 15030517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
